Dhruv Kazi, MD, MS
|School||UCSF School of Medicine|
|Address||1001 Potrero Ave, SFGH 5|
San Francisco CA 94110
|Stanford University, Stanford, CA||Master of Science, Health Services Research ||School of Medicine||2012|
|Stanford University, Stanford, CA||Entrepreneurial Design for Extreme Affordability||Hasso Plattner Institute of Design||2012|
|Stanford University, Stanford, CA||Stanford Ignite – Program in Innovation and Entrepreneurship||Graduate School of Business||2011|
|University of California San Diego, La Jolla, CA||Clinical Fellowship in Cardiovascular Medicine||School of Medicine||2010|
|London School of Economics and Political Science, London, United Kingdom||Master of Science, International Health Policy and Health Economics||2007|
|Baylor College of Medicine: Ben Taub General Hospital and St Luke's Episcopal Hospital, Houston, TX||Chief Residency: Internal Medicine||2006|
|Baylor College of Medicine, Houston, TX||Residency: Internal Medicine||2005|
|Baylor College of Medicine, Houston, TX||Internship: Internal Medicine||2003|
|University of Mumbai, Mumbai, India||Medical Degree||Seth G.S. Medical College||2001|
I am a general cardiologist and a cardiovascular health economist interested in understanding and improving long-term clinical outcomes among patients with cardiovascular disease in the United States and overseas.
My recent work has involved the evaluation of novel diagnostic approaches, medical devices, drug therapy and genetic testing, and has included the creation of discrete-time Markov modeling, as well as the use of advanced statistical techniques for large observational datasets (Medicare, Kaiser, National Inpatient Sample).
I am particularly interested in the optimization of health care expenditures to maximize societal value. For instance, how does one determine the “best” use for scarce resources when considering alternative diagnostic or therapeutic strategies for a given disease or a range of commonly encountered diseases? Rather than viewing optimization as a zero-sum game, can we develop creative ways (for instance, by exploring synergies within the system or using low-cost technologies) to enhance productivity and expand the pie?
I co-founded heartMAP – a low-cost, data-driven program focused on improving medication adherence among low-literacy patients with advanced cardiovascular disease. heartMAP harnesses technology and real-time data analysis to treat and track patients on anticoagulation, using financial and non-financial incentives for stakeholder behavior modification. We are partnering with Narayana Hospitals in Bangalore, India, a pioneer in using industrial systems design to dramatically reduce the cost of cardiovascular surgery, and the Center for Chronic Disease Control in New Delhi, India’s leading private-public partnership for research in non-communicable diseases. See www.heart-map.org for more information.
I aspire to leverage my dual training in cardiology and health economics to help ensure that our investments in healthcare represent true societal value. My clinical training has spanned four continents and included three large safety-net hospitals, three VAs and four quaternary care centers; and my research training has been at two of the world’s leading departments of health policy and health economics. I am confident that the breadth of my clinical and research experiences enables me to provide quality, compassionate health care to my patients, even as I strive to improve the system that delivers it.
health economics, cost-effectiveness, m-health, global health, India, anticoagulation, big data
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.